ImmunityBio (IBRX)

Infacell Therapeutics, Inc. • Inex Bio, Inc. • NantCell, Inc. • Etubics Corporation • Altor BioScience, LLC • Altor BioScience Manufacturing Company, LLC • Receptome, Inc. • VBC Holdings LLC • GlobeImmune, Inc. • Immunotherapy NANTibody, LLC ...

IBRX stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$18.00

Low target

$6.00

High target

$30.00

Latest filings (excl ownership)

View all

424B5

Prospectus supplement for primary offering

12 Dec 24

8-K

ImmunityBio, Inc. Announces Pricing of Public Offering of Common Stock

11 Dec 24

8-K

ImmunityBio, Inc. Announces Proposed Public Offering of Common Stock

10 Dec 24

424B5

Prospectus supplement for primary offering

10 Dec 24

8-K

ImmunityBio Completes ANKTIVA’s Post-Approval Enrollment of the 100th Patient in

12 Nov 24

ImmunityBio Reports Third-Quarter 2024 Financial Results

12 Aug 24

Entry into a Material Definitive Agreement

17 Jul 24

S-8

Registration of securities for employees

20 Jun 24

Latest ownership filings

View all

Financial summary

Financial statements Chart IBRX financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	111.97 mm	111.97 mm	111.97 mm	111.97 mm	111.97 mm	111.97 mm
Cash burn (monthly)	6.05 mm	5.50 mm	28.58 mm	48.99 mm	32.92 mm	35.11 mm
Cash used (since last report)	24.33 mm	22.13 mm	115.04 mm	197.18 mm	132.49 mm	141.32 mm
Cash remaining	87.63 mm	89.83 mm	-3.07 mm	-85.21 mm	-20.53 mm	-29.35 mm
Runway (months of cash)	14.5	16.3	-0.1	-1.7	-0.6	-0.8

Beta Read what these cash burn values mean

Financial data from ImmunityBio earnings reports.

Institutional ownership, Q3 2024

IBRX institutional ownership history Ownership history

49.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	182	193	-5.7%
Opened positions	26	52	-50.0%
Closed positions	37	25	+48.0%
Increased positions	62	60	+3.3%
Reduced positions	40	46	-13.0%

13F shares	Current	Prev Q	Change
Total value	252.66 bn	385.17 bn	-34.4%
Total shares	360.31 mm	353.16 mm	+2.0%
Total puts	1.31 mm	4.12 mm	-68.2%
Total calls	1.68 mm	1.43 mm	+17.6%
Total put/call ratio	0.8	2.9	-73.0%

Largest owners	Shares	Value	Change
Cambridge Equities	291.69 mm	$1.46 bn	0.0%
Vanguard	16.90 mm	$62.88 bn	+22.2%
BlackRock	11.86 mm	$44.11 bn	NEW
STT State Street	8.65 mm	$32.19 bn	+10.1%
Geode Capital Management	3.85 mm	$14.31 bn	-1.8%
MS Morgan Stanley	2.25 mm	$8.36 bn	+295.3%
BAC Bank of America	2.07 mm	$7.70 bn	+115.9%
Ubs Global Asset Management Americas	1.54 mm	$5.75 bn	-2.1%
GS The Goldman Sachs Group, Inc.	1.29 mm	$4.79 bn	+25.8%
Charles Schwab Investment Management	1.27 mm	$4.71 bn	+2.4%

Largest transactions	Shares	Bought/sold	Change
BlackRock	11.86 mm	+11.86 mm	NEW
BLK BlackRock	0.00	-11.42 mm	EXIT
Vanguard	16.90 mm	+3.07 mm	+22.2%
MS Morgan Stanley	2.25 mm	+1.68 mm	+295.3%
Jane Street	95.61 k	-1.62 mm	-94.4%
BAC Bank of America	2.07 mm	+1.11 mm	+115.9%
Millennium Management	1.12 mm	+1.02 mm	+1093.2%
STT State Street	8.65 mm	+790.41 k	+10.1%
D. E. Shaw & Co.	520.05 k	+520.05 k	NEW
RY Royal Bank of Canada	127.54 k	-342.66 k	-72.9%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

IBRX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
22 Jan 25	Simon Barry J.	Common Stock	Option exercise	Acquire M	No	No	1.9984	110,020	219.86 k	3,233,781
22 Jan 25	Simon Barry J.	Stock Option Common Stock	Option exercise	Dispose M	No	No	1.9984	110,020	219.86 k	0
31 Dec 24	Richard Adcock	Common Stock	Payment of exercise	Dispose F	No	No	2.56	17,475	44.74 k	260,146
31 Dec 24	Richard Adcock	Common Stock	Option exercise	Acquire M	No	No	0	34,483	0.00	277,621
31 Dec 24	Richard Adcock	RSU Common Stock	Option exercise	Dispose M	No	No	0	34,483	0.00	86,214
31 Dec 24	David C. Sachs	Common Stock	Payment of exercise	Dispose F	No	No	2.56	15,405	39.44 k	200,830
31 Dec 24	David C. Sachs	Common Stock	Option exercise	Acquire M	No	No	0	30,397	0.00	216,235
31 Dec 24	David C. Sachs	RSU Common Stock	Option exercise	Dispose M	No	No	0	30,397	0.00	75,999
15 Dec 24	Regan J Lauer	Common Stock	Payment of exercise	Dispose F	No	No	2.87	7,503	21.53 k	107,862
15 Dec 24	Regan J Lauer	Common Stock	Option exercise	Acquire M	No	No	0	21,031	0.00	115,365